In hospitals across Europe, barcodes already help verify medicines — but usually only on the outer pack. A new joint push wants to shrink that barcode all the way down to every individual dose: each blister, vial or unit.
The European Association of Hospital Pharmacists (EAHP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) released joint guidance on September 7, 2026 calling for unit-dose barcodes. Under the plan, all new products would carry them from 2031, with existing medicines updated gradually.
Why single-dose barcodes
Since 2019, the EU’s Falsified Medicines Directive has required barcodes carrying a product code, batch number and expiry on prescription packs — mainly to fight counterfeits. Extending them to each dose targets a different problem: giving the right drug to the right patient at the bedside. Research cited in the guidance says bedside barcode scanning cuts medication errors by 30–60%, and a New England Journal of Medicine study suggested unit-dose barcodes could reduce error rates by 41%.
Why it matters
Medication errors cause avoidable harm, longer hospital stays and readmissions, so a scan-to-verify step at the point of care is a meaningful safety win. “Over the next five years, all new medicines will include a barcode on every dose,” said EFPIA director general Nathalie Moll. The obstacles are practical, not conceptual: tiny pack dimensions and manufacturer investment. This is an industry proposal and target timeline, not yet binding law.